Sökning: id:"swepub:oai:gup.ub.gu.se/63491" >
Survival of patient...
Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home
-
- Gustafson, T. (författare)
- Umeå universitet,Institutionen för folkhälsa och klinisk medicin
-
- Franklin, Karl (författare)
- Umeå universitet,Institutionen för folkhälsa och klinisk medicin
-
Midgren, B. (författare)
-
visa fler...
-
- Pehrsson, Kerstin (författare)
- Lund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin,Institute of Medicine, Department of Internal Medicine,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
-
Ranstam, J. (författare)
-
Ström, K. (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2006
- 2006
- Engelska.
-
Ingår i: Chest. - : Elsevier BV. - 0012-3692 .- 1931-3543. ; 130:6, s. 1828-33
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
http://www.ncbi.nlm....
-
https://gup.ub.gu.se...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Home mechanical ventilation (HMV) and long-term oxygen therapy (LTOT) are the two treatment alternatives when treating respiratory insufficiency in patients with kyphoscoliosis. We aimed to study the effect on survival with regard to HMV or LTOT alone in patients with respiratory insufficiency due to kyphoscoliosis. METHODS: Swedish patients with nonparalytic kyphoscoliosis (ie, scoliosis not related to neuromuscular disorders) who started LTOT or HMV between 1996 and 2004 were followed up prospectively until February 14, 2006, with death as the primary outcome. Treatment modality, arterial blood gas levels, the presence of concomitant respiratory diseases, and age were recorded at the onset of treatment. No patient was lost to follow-up. RESULTS: One hundred patients received HMV, and 144 patients received oxygen therapy alone. Patients treated with HMV experienced better survival, even when adjusting for age, gender, concomitant respiratory diseases, and blood gas levels, with a hazard ratio of 0.30 (95% confidence interval, 0.18 to 0.51). CONCLUSION: The survival of patients with kyphoscoliosis receiving HMV was better than that of patients treated with LTOT alone. We suggest HMV and not oxygen therapy alone as the primary therapy for patients with respiratory failure due to kyphoscoliosis, regardless of gender, age, and the occurrence of concomitant respiratory diseases.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Nyckelord
- Aged
- Aged
- 80 and over
- Confidence Intervals
- Female
- Follow-Up Studies
- *Home Care Services
- Hospital-Based
- Humans
- Kyphosis/*complications/mortality
- Long-Term Care
- Male
- Middle Aged
- *Oxygen Inhalation Therapy
- Proportional Hazards Models
- Prospective Studies
- *Respiration
- Artificial
- Respiratory Insufficiency/mortality/*therapy
- Scoliosis/*complications/mortality
- Survival Analysis
- long-term oxygen therapy
- kyphoscoliosis
- mechanical ventilation
- survival
- respiratory failure
- treatment
- Swedevox
- Aged
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Chest
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas